Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01742143 · ClinicalTrials.gov registry record
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
A clinical trial of Cancer Patients, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 347
- Enrollment target
- 11
- Study locations
NCT01742143: Recruiting study of Cancer Patients, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01742143 is a study of Cancer Patients that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 347 participants, above the 201-participant average among 8 other Cancer Patients trials with a reported enrollment target (73% higher). The trial reports 11 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01742143, a study of Cancer Patients, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 347 participants
- Enrollment target
- 11
- Study locations
Study Summary
The purpose of this 1 year study is to see if the ICCAN program is working, and to compare the ICCAN program to the standard hospital services provided in New York City hospitals, like meeting with a Social Worker or a Patient Navigator (a person who provides personal hospital guidance).
Primary Outcome
The primary outcome, cancer treatment completion, will be determined by chart review at 3, 6, and 12 months after enrollment.
Conditions Studied
Interventions
- BEHAVIORAL The Integrated Cancer Care Access Network (ICCAN)
- BEHAVIORAL Usual and Customary Group (U&C)
Study Locations (11)
New York
- Lutheran Medical Center - Brooklyn
- Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) - Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities) - Harrison
- City College of New York (Data Collection AND Data Analysis) - New York
- Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities) - New York
- Memorial Sloan Kettering Cancer Center - New York
- Memorial Sloan Kettering Nassau (Limited Protocol Activities) - Rockville Centre
- Lincoln Hospital and Mental Health Center - The Bronx
New Jersey
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) - Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) - Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 347 participants |
| Start Date | 2012-11 |
| Est. Completion | 2026-11 |
What NCT01742143 shows while recruiting
NCT01742143 is an observational study that tracks outcomes without assigning an intervention. The registered 347 participants enrollment target is mid-sized for trials with a published cap, above the 201-participant average among 8 other Cancer Patients trials with a reported enrollment target (73% higher).
The record links to 1 condition, with Cancer Patients appearing as the primary indexed condition, and to 2 interventions - of which The Integrated Cancer Care Access Network (ICCAN) is the first listed.
NCT01742143 lists 11 locations in 2 states (New York, New Jersey).
Frequently Asked Questions
What is clinical trial NCT01742143 about?
NCT01742143 is a clinical study titled "Impact of ICCAN on Cancer Treatment Completion and Quality of Life". The purpose of this 1 year study is to see if the ICCAN program is working, and to compare the ICCAN program to the standard hospital services provided in New York City hospitals, like meeting with a Social Worker or a Patient Navigator (a person who provides personal hospital guidance).
What is the current status of trial NCT01742143?
This trial is currently recruiting. The enrollment target is 347 participants. The study started on 2012-11. Estimated completion is 2026-11.
What conditions does trial NCT01742143 study?
This clinical trial studies the following conditions: Cancer Patients.
What interventions are being tested in trial NCT01742143?
The interventions under investigation include: The Integrated Cancer Care Access Network (ICCAN) (BEHAVIORAL), Usual and Customary Group (U&C) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01742143?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01742143 being conducted?
This trial has 11 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer Patients
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01742143's enrollment target sits among peer trials
347 3rd of 8 higher than 6 of 8 other Cancer Patients trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer Patients trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study Testing Topical Pain-Relieving Herbal Plasters in People Who Are Using Opioids for Their Pain
RECRUITING · Phase 1
-
Use of a Comprehensive, Mobile Application to Assist Cancer Patients With Diet, Nutrition and Activity
RECRUITING · NA
-
A Study of an Anxiety Intervention for Latino/Latina/Hispanic Older Adults With Cancer and Their Caregivers
RECRUITING · NA
-
Writing Intervention With Adolescents and Young Adults With Cancer
RECRUITING · NA
-
Food: A Three-Arm Study Examining Food Insecurity Interventions
ACTIVE NOT RECRUITING · Phase 2
-
A Study Comparing Two Types of Supportive Interventions for Caregivers of Patients With Cancer
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04877522 · 347 participants · Phase 4
Asciminib Roll-over Study
- NCT05834660 · 347 participants · NA
SAFETY-A for Promoting Equity in Suicide Prevention Outcomes in Schools
- NCT06963827 · 347 participants · Phase 3
A Study of Mezagitamab in Adults With Primary IgA Nephropathy Kidney Condition
- NCT04041479 · 348 participants · Phase 3
Biomarker-guided rTMS for Treatment Resistant Depression
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia